Blueshift Asset Management’s CONMED CNMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
– Sell
-4,366
Closed -$418K – 631
2022
Q2
$418K Buy
+4,366
New +$524K 0.07% 365
2021
Q2
– Sell
-2,647
Closed -$346K – 945
2021
Q1
$346K Sell
2,647
-6,033
-70% -$726K 0.04% 592
2020
Q4
$972K Buy
8,680
+1,045
+14% +$98.9K 0.12% 273
2020
Q3
$601K Buy
+7,635
New +$623K 0.08% 307

Other funds holding CNMD

Blueshift Asset Management's CNMD Position: Q3 2022 in Review

Blueshift Asset Management sold out of CONMED (CNMD) in Q3 2022, closing a stake of 4,366 shares — an estimated $418K sold.

Blueshift Asset Management first reported a position in CNMD in Q3 2020 and held it in 4 quarters. The position peaked at $972K in Q4 2020. 250 funds tracked by Wall St. Rank hold CNMD as of Q3 2022.

  • Blueshift Asset Management reported no remaining CONMED position as of Q3 2022 after selling out during the quarter.
  • Blueshift Asset Management sold 4,366 CONMED shares in Q3 2022, an estimated $418K.
  • Blueshift Asset Management first reported a position in CONMED in Q3 2020 and held it in 4 quarters.
  • Blueshift Asset Management's CONMED position peaked at $972K in Q4 2020.
  • 250 funds tracked by Wall St. Rank held CONMED as of Q3 2022.

Based on Blueshift Asset Management's 13F filing for Q3 2022, filed 14 Nov 2022.